Dáil Éireann Debate, Tuesday - 22 March 2022
1058. Deputy Róisín Shortall asked the Minister for Health the status of the European Commission Joint Procurement Agreement for the supply of other antivirals and monoclonal antibody treatments; and if he will make a statement on the matter. [14908/22]
Amharc ar fhreagraThe EU Commission is currently progressing a Joint Procurement Agreement (JPA) in relation to antivirals, which includes MSD’s Lagevrio (Molnupiravir) and Pfizer’s Paxlovid (PF-07321332; Ritonavir). Ireland has formally indicated its intention to participate in this arrangement. Ireland is already a participant in an EU JPA for the purchase of the GSK monoclonal antibody product Xevudy (Sotrovimab), and has made orders for and received deliveries of Xevudy via this process.
